PANews reported on November 22 that according to PR Newswire, the U.S. listed company Anixa Biosciences, Inc. (NASDAQ: ANIX) announced that its board of directors has approved the purchase of Bitcoin as a treasury reserve asset, aiming to diversify the company's assets while enabling Anixa to benefit from the potential long-term value of digital assets.
It is reported that Anixa is a clinical-stage biotechnology company focusing on cancer treatment and prevention.
XRP leads the rise, old-line currencies recover, is the full-scale altcoin season coming?
CBOE to launch first cash-settled options product tied to spot Bitcoin on December 2
Bitdeer announces issuance of $360 million convertible senior notes
Calamos Investments to Hedge Against Bitcoin Volatility by Launching New ETF
Galaxy CEO: Trump Cabinet Members Generally Own Bitcoin
Interactive Strength's board of directors approves purchase of $5 million in Bitcoin as reserve assets
Web3 is entering an era of great development, with new projects emerging continuously. This special topic collects, organizes, and screens these new projects, hoping that readers can capture new narratives from them.
Exclusive interviews with crypto celebrities, sharing unique observations and insights
The 2024 US presidential election is approaching its final moment, and the world is focusing on it. Will the United States welcome its first "crypto president" or its first female president? How will it affect the crypto market? PANews will track the 2024 US presidential election in real time.
PAData PAData PAData
